Cargando…
Tumor copy-number alterations predict response to immune-checkpoint-blockade in gastrointestinal cancer
BACKGROUND: Despite the great achievements made in immune-checkpoint-blockade (ICB) in cancer therapy, there are no effective predictive biomarkers in gastrointestinal (GI) cancer. METHODS: This study included 93 metastatic GI patients treated with ICBs. The first cohort comprising 73 GI cancer pati...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430454/ https://www.ncbi.nlm.nih.gov/pubmed/32792358 http://dx.doi.org/10.1136/jitc-2019-000374 |